| Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients DA Mitchell, KA Batich, MD Gunn, MN Huang, L Sanchez-Perez, SK Nair, ... Nature 519 (7543), 366-369, 2015 | 489 | 2015 |
| Th17 cells are long lived and retain a stem cell-like molecular signature P Muranski, ZA Borman, SP Kerkar, CA Klebanoff, Y Ji, L Sanchez-Perez, ... Immunity 35 (6), 972-985, 2011 | 452 | 2011 |
| Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity CS Hinrichs, ZA Borman, L Cassard, L Gattinoni, R Spolski, Z Yu, ... Proceedings of the National Academy of Sciences 106 (41), 17469-17474, 2009 | 434 | 2009 |
| Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors P Chongsathidkiet, C Jackson, S Koyama, F Loebel, X Cui, SH Farber, ... Nature medicine 24 (9), 1459-1468, 2018 | 406 | 2018 |
| T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in GlioblastomaT-Cell Exhaustion Signatures in Glioblastoma K Woroniecka, P Chongsathidkiet, K Rhodin, H Kemeny, C Dechant, ... Clinical Cancer Research 24 (17), 4175-4186, 2018 | 398 | 2018 |
| EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen LossEGFRvIII mCARs for Malignant Glioma JH Sampson, BD Choi, L Sanchez-Perez, CM Suryadevara, DJ Snyder, ... Clinical Cancer Research 20 (4), 972-984, 2014 | 297 | 2014 |
| Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsTumor Destruction Using IL-12-Engineered T Cells SP Kerkar, P Muranski, A Kaiser, A Boni, L Sanchez-Perez, Z Yu, ... Cancer research 70 (17), 6725-6734, 2010 | 278 | 2010 |
| Type 17 CD8+ T cells display enhanced antitumor immunity CS Hinrichs, A Kaiser, CM Paulos, L Cassard, L Sanchez-Perez, ... Blood, The Journal of the American Society of Hematology 114 (3), 596-599, 2009 | 255 | 2009 |
| Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination KA Batich, EA Reap, GE Archer, L Sanchez-Perez, SK Nair, ... Clinical Cancer Research 23 (8), 1898-1909, 2017 | 231 | 2017 |
| Brain tumor microenvironment and host state: implications for immunotherapy W Tomaszewski, L Sanchez-Perez, TF Gajewski, JH Sampson Clinical Cancer Research 25 (14), 4202-4210, 2019 | 183 | 2019 |
| Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells C Cole, J Qiao, T Kottke, RM Diaz, A Ahmed, L Sanchez-Perez, G Brunn, ... Nature medicine 11 (10), 1073-1081, 2005 | 178 | 2005 |
| Toll-like receptors in tumor immunotherapy CM Paulos, A Kaiser, C Wrzesinski, CS Hinrichs, L Cassard, A Boni, ... Clinical Cancer Research 13 (18), 5280-5289, 2007 | 160 | 2007 |
| Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma BD Choi, CT Kuan, M Cai, GE Archer, DA Mitchell, PC Gedeon, ... Proceedings of the National Academy of Sciences 110 (1), 270-275, 2013 | 155 | 2013 |
| EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma H Miao, BD Choi, CM Suryadevara, L Sanchez-Perez, S Yang, G De Leon, ... PloS one 9 (4), e94281, 2014 | 136 | 2014 |
| A simple method to cure established tumors by inflammatory killing of normal cells GA Daniels, L Sanchez-Perez, RM Diaz, T Kottke, J Thompson, M Lai, ... Nature biotechnology 22 (9), 1125-1132, 2004 | 135 | 2004 |
| Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer T Kottke, L Sanchez-Perez, RM Diaz, J Thompson, H Chong, K Harrington, ... Cancer research 67 (24), 11970-11979, 2007 | 117 | 2007 |
| Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma BD Choi, CM Suryadevara, PC Gedeon, JE Herndon II, L Sanchez-Perez, ... Journal of clinical neuroscience 21 (1), 189-190, 2014 | 116 | 2014 |
| Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans DA Mitchell, X Cui, RJ Schmittling, L Sanchez-Perez, DJ Snyder, ... Blood, The Journal of the American Society of Hematology 118 (11), 3003-3012, 2011 | 114 | 2011 |
| Genetic engineering of murine CD8+ and CD4+ T cells for pre-clinical adoptive immunotherapy studies SP Kerkar, L Sanchez-Perez, S Yang, Z Borman, P Muranski, Y Ji, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 34 (4), 343, 2011 | 114 | 2011 |
| Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo L Sanchez-Perez, T Kottke, RM Diaz, A Ahmed, J Thompson, H Chong, ... Cancer research 65 (5), 2009-2017, 2005 | 101 | 2005 |
